I agree that this site is using cookies. You can find further informations here.
X
Oberic, L.
319  results:
english X
Search for persons X
?
1

VERY LONG‐TERM FOLLOW‐UP OF RITUXIMAB MAINTENANCE IN YOUNG ..:

Sarkozy, C. ; Thieblemont, C. ; Oberic, L....
Hematological Oncology.  41 (2023)  S2 - p. 151-152 , 2023
Link: https://doi.org/10.1002/..
 
?
2

Tafasitamab lenalidomide in relapsed/refractory large B‐cel..:

Paillassa, J. ; Degoutte, C. ; Oberic, L....
Hematological Oncology.  41 (2023)  S2 - p. 591-592 , 2023
Link: https://doi.org/10.1002/..
 
?
3

Efficacy of anti‐PD1 therapy in relapsed or refractory NK/T..:

Marouf, A. ; Chaubard, S. ; Michot, J....
Hematological Oncology.  41 (2023)  S2 - p. 502-503 , 2023
Link: https://doi.org/10.1002/..
 
?
4

Molecular and clinical diversity in primary central nervous..:

Hernández-Verdin, I. ; Kirasic, E. ; Wienand, K....
Annals of Oncology.  34 (2023)  2 - p. 186-199 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Brigatinib in patients with ALK‐positive anaplastic large c..:

Veleanu, L. ; Tesson, B. ; Lamant, L....
Hematological Oncology.  41 (2023)  S2 - p. 505-506 , 2023
Link: https://doi.org/10.1002/..
 
?
6

EARLY CTDNA CLEARANCE AFTER CAR T‐CELL INFUSION PREDICTS OU..:

Delfau‐Larue, M. ; Viailly, P. ; Cartron, G....
Hematological Oncology.  41 (2023)  S2 - p. 179-181 , 2023
Link: https://doi.org/10.1002/..
 
?
7

AXICABTAGENE CILOLEUCEL AS SECOND‐LINE THERAPY FOR LARGE B‐..:

Houot, R. ; Bachy, E. ; Cartron, G....
Hematological Oncology.  41 (2023)  S2 - p. 147-148 , 2023
Link: https://doi.org/10.1002/..
 
?
8

LONG‐TERM OUTCOMES OF ELDERLY PATIENTS TREATED WITH FRONTLI..:

Camus, V. ; Belot, Aurél. ; Oberic, L....
Hematological Oncology.  39 (2021)  S2 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
9

HIGH‐RISK MANTLE CELL LYMPHOMA IN THE LYMA TRIAL: A LYSA ST..:

Cheminant, M. ; Burroni, B. ; Le Bris, Y....
Hematological Oncology.  39 (2021)  S2 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
10

ACALABRUTINIB MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACT..:

Wang, M. ; Rule, S. ; Zinzani, P. L....
Hematological Oncology.  39 (2021)  S2 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
11

REAL WORLD OUTCOME IN MANTLE CELL LYMPHOMA: A FRENCH RETROS..:

Branco, B ; Bories, P ; Ysebaert, L...
Hematological Oncology.  39 (2021)  S2 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
12

Efficacy of dupilumab in eosinophilic dermatosis of haemato..:

Sibaud, V. ; Brun, A. ; Meyer, N....
Journal of the European Academy of Dermatology and Venereology.  36 (2021)  3 - p. , 2021
Link: https://doi.org/10.1111/..
 
?
13

Orbital exenteration and conjunctival melanoma: a 14-year s..:

Martel, A. ; Oberic, A. ; Moulin, A....
Eye.  34 (2020)  10 - p. 1897-1902 , 2020
Link: https://doi.org/10.1038/..
 
?
14

OBINUTUZUMAB PLUS DHAP FOLLOWED BY AUTOLOGOUS STEM CELL TRA..:

Le Gouill, S. ; Beldi‐Ferchiou, A. ; Cacheux, V....
Hematological Oncology.  37 (2019)  S2 - p. 44-45 , 2019
Link: https://doi.org/10.1002/..
 
?
15

IBRUTINIB ABOVE 79 YEARS OLD FOR CHRONIC LYMPHOCYTIC LEUKEM..:

Calleja, A. ; Branco, B. ; Teste, A....
Hematological Oncology.  37 (2019)  S2 - p. 384-384 , 2019
Link: https://doi.org/10.1002/..
 
1-15